UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000052286 |
|---|---|
| Receipt number | R000059688 |
| Scientific Title | Frequency of Hypertension in Childhood Cancer Survivors: a systematic review and meta-analysis |
| Date of disclosure of the study information | 2023/10/01 |
| Last modified on | 2023/09/22 23:53:22 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Frequency of Hypertension in Childhood Cancer Survivors: a systematic review and meta-analysis
Acronym
Frequency of Hypertension in Childhood Cancer Survivors: a systematic review and meta-analysis
Scientific Title
Frequency of Hypertension in Childhood Cancer Survivors: a systematic review and meta-analysis
Scientific Title:Acronym
Frequency of Hypertension in Childhood Cancer Survivors: a systematic review and meta-analysis
Region
| Japan |
Condition
Condition
Childhood Cancers
Classification by specialty
| Medicine in general | Cardiology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
A Systematic Review and Meta-Analysis of the Incidence of Hypertension in Childhood Cancer Survivors
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The primary outcome: The prevalence of hypertension will be pooled using random effects model meta-analysis.
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
(1) Studies are case-control studies, cohort studies, or randomized clinical trials.
(2) Studies are of clinically diagnosed pediatric malignancies and include survivor patients.
(3) Studies are reporting on the complications of hypertension.
Key exclusion criteria
(1)A systematic review or meta-analysis article.
(2)Case reports or case series with fewer than 5 cases.
(3)Exclude republished research literature unless it contains new findings related to hypertension.
(4)Studies published in languages other than English.
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Shintaro |
| Middle name | |
| Last name | Minegishi |
Organization
Yokohama City University Graduate School of Medicine
Division name
Department of Cardiology
Zip code
236-0004
Address
3-9, Kanazawa, Fukuura, Yokohama
TEL
045-787-2635
minegishi.shi.fb@yokohama-cu.ac.jp
Public contact
Name of contact person
| 1st name | Shintaro |
| Middle name | |
| Last name | Minegishi |
Organization
Yokohama City University Graduate School of Medicine
Division name
Department of Cardiology
Zip code
236-0004
Address
3-9, Kanazawa, Fukuura, Yokohama
TEL
045-787-2635
Homepage URL
minegishi.shi.fb@yokohama-cu.ac.jp
Sponsor or person
Institute
Yokohama City University Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Self funding
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Yokohama City University Graduate School of Medicine
Address
3-9, Kanazawa, Fukuura, Yokohama
Tel
045-787-2635
minegishi.shi.fb@yokohama-cu.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 10 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2023 | Year | 09 | Month | 22 | Day |
Date of IRB
Anticipated trial start date
| 2023 | Year | 09 | Month | 22 | Day |
Last follow-up date
| 2024 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Candidate papers will be searched in October 2023 using PubMed, Cochrane, EMBASE, and Web of Science Core Collection. Hand searches will be conducted by two persons.
Participants: Childhood Cancer Survivors
Intervention: Treatment of malignant tumors
Comparison: None
Outcome: Development of hypertension
Two investigators will independently review all titles, abstracts, and full texts for eligibility. Final inclusion will be determined after resolution of any discrepancies between the two investigators.
The risk of bias for each study will be assessed using the Newcastle-Ottawa Scale for Cohort Studies.
Management information
Registered date
| 2023 | Year | 09 | Month | 22 | Day |
Last modified on
| 2023 | Year | 09 | Month | 22 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059688
